October 16, 2018 / 3:52 PM / a month ago

FDA approves Pfizer's breast cancer drug

Oct 16 (Reuters) - The U.S. Food and Drug Administration said here on Tuesday it approved Pfizer Inc's drug for advanced form of breast cancer.

The FDA also approved Myriad Genetics’ diagnostic test to identify breast cancer patients who are eligible for Pfizer’s drug, talazoparib. (Reporting by Manogna Maddipatla in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below